Metabolic Activation of Racemic and Enantiomeric trans-8,9-Dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (Dibenzo[def,p]chrysene) to Dibenzo[a,l]pyrene-bis-dihydrodiols by Induced Rat Liver Microsomes and a Recombinant Human P450 1A1 System: The Role of the K-Region-Derived Metabolic Intermediates in the Formation of Dibenzo[a,l]pyrene−DNA Adducts
Tóm tắt
Từ khóa
Tài liệu tham khảo
International Agency for Research on Cancer (1983) Polynuclear aromatic compounds, Part 1, chemical, environmental and experimental data.Monographs on the evaluation of carcinogenic risk of chemicals to man, Vol. 32, p 477, International Agency for Research on Cancer, Lyon, France.
Snook M. E., 1977, Beitr. Tabakforsch., 9, 101
Mumford J. L., 1995, China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis 16, 3031−3036.
Kozin I. S., 1995, Direct determination of dibenzo[a,l]pyrene in crude extracts of environmental samples by laser excited Shpol'skii spectroscopy. Anal. Chem. 67, 1623−1626
Cavalieri E. L., 1991, Carcinogenesis 12
Higginbotham S., 1993, Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis 14, 875−878, 10.1093/carcin/14.5.875
Harvey, R. G. (1991)Polycyclic Aromatic Hydrocarbons, Chemistry and Carcinogenicity, p 396, Cambridge University Press, New York.
Devanesan P. D., 1990, Metabolism and mutagenicity of dibenzo[a,e]pyrene and the very potent environmental carcinogen dibenzo[a,l]pyrene. Chem. Res. Toxicol. 3, 580−586
Nesnow S., 1998, Biotransformation and DNA adduct formation of trans-8,9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene by induced rat liver and human P450 1A1 microsomes. Polycyclic Aromat. Compd. (in press)
Shou M., 1996, Metabolic activation of the potent carcinogen dibenzo[a,l]pyrene by human recombinant cytochromes P450, lung and liver microsomes. Carcinogenesis 17, 2429−2433
Seidel, A., Luch, A., Platt, K. L., Oesch, F., and Glatt, H. (1994) Activated fjord-region metabolites of dibenzo[a,l]pyrene: synthesis and mutagenic activities of the diastereomericsyn- andanti-11,12-dihydrodiol-13,14-epoxides.Polycyclic Aromat. Compd.6, 191−198.
Ralston, S. L., Seidel, A., Luch, A., Platt, K. L., and Baird, W. M. (1995) Stereoselective activation of dibenzo[a,l]pyrene to (−)-anti-(11R,12S,13S,14R)- and (+)-syn-(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7.Carcinogenesis16, 2899−2907.
Ralston S. L., 1994, Identification of dibenzo[a,l]pyrene-DNA adducts formed in cells in culture and in mouse skin. Polycyclic Aromat. Compd. 6, 199−206
Li K.-M., 1995, Identification and quantitation of dibenzo[a,l]pyrene-DNA adducts formed by rat liver microsomes in vitro: preponderance of depurinating adducts. Biochemistry 34, 8043−8049
Arif J. M., 1997, Carcinogenesis 18
Amin, S., Desai, D., Dai, W., Harvey, R. G., and Hecht, S. S. (1995) Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene, and fluoranthene.Carcinogenesis16, 2813−2817.
Arif J. A., 1997, Mutat. Res., 378, 39
Reddy A., 1997, Proc. Am. Cancer Soc., 38, 127
Chakravarti D., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
Harvey, R. G. (1991)Polycyclic Aromatic Hydrocarbons, Chemistry and Carcinogenicity, pp 306−310, Cambridge University Press, New York.
Nesnow S., 1993, Cancer Lett., 73
Gupta R. C., 1982, 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3, 1081−1092
Reddy M. V., 1986, Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7, 1543−1551
Gupta R. C., 1988, 32P-Postlabeling assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis 9, 1687−1693
King L. C., 1994, Separation of 32P-postlabeled DNA adducts of polycyclic aromatic hydrocarbons and nitrated polycyclic aromatic hydrocarbons by HPLC. Chem. Res. Toxicol. 7, 503−510
Dewar M. J. S., 1985, J. Am. Chem. Soc., 107
Wavefunction, Inc. (1997)Spartan, version 5.0, 18401 Von Karman Ave., Suite 370, Irvine, CA 92612.
Anderson W. P., 1986, Calculated spectra of hydrated ions of the first transition metal series. Inorg. Chem. 25, 2728−2732
Hypercube, Inc. (1995)HyperChem, release 4.5, 419 Phillip St., Waterloo, ON N2L 3X2, Canada.
Gill, H. S., Kole, P. L., Wiley, J. C., Li, K.M., Higginbotham, S., Rogan, E. G., and Cavalieri, E. C. (1994) Synthesis and tumor initiating activity in mouse skin of dibenzo[a,l]pyrenesyn- andanti-fjord-region diolepoxides.Carcinogenesis15, 2455−2460.
Luch A., 1998, Synthesis of fjord region tetraols and their use in hepatic biotransformation studies 1607 of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a,l]pyrene. Carcinogenesis 19, 639−648
Prahalad A. K., 1997, Carcinogenesis 18
Nesnow S., 1997, Carcinogenesis 18
Luch A., 1997, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells. Chem. Res. Toxicol. 10, 1161−1170.
Ralston, S. L., Coffing, S. L., Seidel, A., Luch, A., Platt, K.L., and Baird, W. M. (1997) Stereoselective activation of dibenzo[a,l]pyrene and itstrans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.Chem. Res. Toxicol.10, 687−693.
Nordqvist M., 1981, Metabolism of chrysene, and phenanthrene to bay-region diol epoxides by rat liver enzymes. Mol. Pharmacol. 19, 168−178
Yang S. K., 1988, Biochem. Pharmacol., 37, 70
Mustaq M., 1989, Chem. Res. Toxicol., 2, 93
Yang S. K., 1987, Arch. Biochem. Biophys., 255, 63
Shou M., 1996, Steroselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. Biochemistry 35, 15807−15813
Thakker D. R., 1976, Proc. Natl. Acad. Sci. U.S.A. 73
Lecoq S., 1991, Microsomal metabolism of dibenz[a,c]anthracene, dibenz[a,h]anthracene, and dibenz[a,j]anthracene to bis-dihydrodiol and polyhydroxylated products. Chem.-Biol. Interact. 80, 261−279
Vyas K. P., 1983, Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes. Mol. Pharmacol. 24, 115−123
Thakker D. R., 1986, J. Biol. Chem., 261
Carmichael P. L., 1993, Evidence for the involvement of a bis-diol-epoxide in the metabolic activation of dibenz[a,h]anthracene to DNA-binding species in mice. Cancer Res. 53, 944−948
Nesnow, S., Ross, J., Beck, S., Lasley, J., Nelson, G., Lambert, G., and Agarwal, S. C. (1994) Morphological transformation and DNA adduct formation by dibenz[a,h]anthracene and its metabolites in C3H10T1/2CL8 cells.Carcinogenesis15, 2225−2231.
Luch A., 1998, Stable expression of human cytochrome P-450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene. Chem. Res. Toxicol. 11, 686−695
Abbreviations BNF, dibenzo[a,l]pyrene